Koers GINO BIOW Nasdaq
Aandelen
DNA
US37611X1000
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 223 mln. 208 mln. | Omzet 2025 * | 310 mln. 289 mln. | Marktkapitalisatie | 1,56 mld. 1,45 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -631 mln. -588 mln. | Nettowinst (verlies) 2025 * | -534 mln. -498 mln. | EV/omzet 2024 * | 3,94 x |
Nettoliquiditeiten 2024 * | 676 mln. 630 mln. | Nettoliquiditeiten 2025 * | 550 mln. 512 mln. | EV/omzet 2025 * | 3,25 x |
K/w-verhouding 2024 * |
-2,43
x | K/w-verhouding 2025 * |
-2,86
x | Werknemers | 1.218 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 66,98% |
Recentste transcriptie over GINO BIOW
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Austin Che
FOU | Founder | - | 01-01-08 |
Founder | - | 01-01-08 | |
Reshma Shetty
FOU | Founder | 43 | 01-01-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 16-09-21 |
Marijn Dekkers
CHM | Chairman | 65 | 16-09-21 |
Kathy Hannan
BRD | Director/Board Member | 62 | 02-08-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+47,02% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |